[ad_1]
The Central Department of Pharmaceutical Affairs of the Ministry of Health issued a circular for governorate health directorates to monitor and edit any 420 mg perjeta preparation.
This came on the basis of what has been reported by companies that the preparations that these operations were cheated on the market as well as the construction of the badysis of the national authority for drug control and of research do not match.
[ad_2]
Source link
